Journal article icon

Journal article

Sex-specific molecular signatures in persistent pain after whiplash injury: an exploratory analysis

Abstract:
Introduction:
Whiplash-associated disorder grade II (WADII) is characterised by persistent pain in the absence of frank nerve injury, yet its molecular mechanisms remain unclear.
Objectives:
To identify molecular signatures of two recovery groups characterised by persistent moderate/severe and minimal symptoms in WADII using RNA-sequencing of blood samples 6 months postinjury.
Methods:

We performed bulk transcriptional analyses on blood samples collected from the primary cohort of individuals with WADII 6 months post-injury (n=15/recovery group). Findings were replicated through metaanalyses using an independent cohort of chronic WAD. Blood cellular composition was estimated via deconvolution analyses across both cohorts.
Results:
Although there were no differentially expressed genes between recovery groups, we identified sexspecific gene expression signatures of recovery. In the primary WADII cohort, HLA-DQA1, HEBP1, and NECTIN2 showed lower expression in females with moderate/severe symptoms compared to minimal symptoms. SLC12A1 and MXRA7 showed lower expression in males with moderate/severe pain, while HLA-G was upregulated. Gene expression meta-analysis in females identified six differentially expressed genes, including replication of lower HLA-DQA1 expression from the primary cohort. There were no differentially expressed genes in the meta-analyses in males or between recovery groups. Deconvolution analyses revealed diverging trends between sexes for blood cell types and whiplash symptom severity scores. Ligand-receptor pair analyses further suggested distinct sex-specific recovery trajectories.
Conclusion:
Transcriptional profiling revealed sex-specific molecular blood signatures associated with persistent whiplash symptoms 6 months post-injury. Future research is needed to further characterise sexspecific mechanisms post-whiplash injury to improve prognosis and targeted management strategies.
Publication status:
Accepted
Peer review status:
Peer reviewed

Actions

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
ORCID:
0000-0001-9237-5878


More from this funder
Funder identifier:
https://ror.org/050rgn017
Grant:
19/0005984
More from this funder
Funder identifier:
https://ror.org/02jkpm469
Grant:
22465
More from this funder
Funder identifier:
https://ror.org/029chgv08
Grant:
222101/Z/20/Z
More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MR/W002388/1
More from this funder
Funder identifier:
https://ror.org/001aqnf71
Grant:
MR/W002388/1


Publisher:
Lippincott, Williams & Wilkins
Journal:
PAIN Reports More from this journal
Acceptance date:
2026-05-30
EISSN:
2471-2531


Language:
English
Keywords:
Pubs id:
2427436
Local pid:
pubs:2427436
Deposit date:
2026-05-31
ARK identifier:


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP